Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase
Prostate cancer is the second leading cause of cancer in men across the globe. The prostate gland accounts for some unique glycolytic metabolic characteristics, which causes the metabolic features of prostate tumor initiation and progression to remain poorly characterized. The mitochondrial superoxi...
Main Authors: | Isabel Quiros-Gonzalez, Pedro Gonzalez-Menendez, Juan C. Mayo, David Hevia, Francisco Artime-Naveda, Sheila Fernandez-Vega, Mario Fernandez-Fernandez, Pablo Rodriguez-Gonzalez, José I. Garcia-Alonso, Rosa M. Sainz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/2/313 |
Similar Items
-
Insights into Manganese Superoxide Dismutase and Human Diseases
by: Mengfan Liu, et al.
Published: (2022-12-01) -
Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
by: Tuna A, et al.
Published: (2017-12-01) -
Manganese Superoxide Dismutase Acetylation and Regulation of Protein Structure in Breast Cancer Biology and Therapy
by: Meredith M. Ogle, et al.
Published: (2022-03-01) -
Gene Therapy for Systemic or Organ Specific Delivery of Manganese Superoxide Dismutase
by: Joel S. Greenberger, et al.
Published: (2021-06-01) -
Changes in the Activity and Concentration of Superoxide Dismutase Isoenzymes (Cu/Zn SOD, MnSOD) in the Blood of Healthy Subjects and Patients with Acute Pancreatitis
by: Milena Ściskalska, et al.
Published: (2020-10-01)